Caplin Point Laboratories Stock Value
Caplin Point Laboratories Company Info
EPS Growth 5Y
20,03%
Market Cap
Rp118,37 B
Long-Term Debt
Rp0,00 B
Annual earnings
05/14/2026 (E)
Dividend
Rp6,02
Dividend Yield
0,40%
Founded
1990
Industry
Country
Website
ISIN Number
Website
Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
Rp2.500,00
66.1%
Last Update: 03/31/2026
Analysts: 1
Highest Price Target Rp2.500,00
Average Price Target Rp2.500,00
Lowest Price Target Rp2.500,00
In the last five quarters, Caplin Point Laboratories’s Price Target has risen from Rp1.163,06 to Rp1.471,50 - a 26,52% increase. One analysts predict that Caplin Point Laboratories’s share price will increase in the coming year, reaching Rp2.500,00. This would represent an increase of 66,10%.
Top growth stocks in the health care sector (5Y.)
What does Caplin Point Laboratories do?
Caplin Point Laboratories Limited engages in development, manufacture, and marketing of a broad range of pharmaceutical products such as injectable medications, tablets, and syrup formulations.
Business Segments
The company operates through various business segments such as: Injectable Pharmaceuticals, Formulations, and Research, Exports, Contract Manufacturing, and Development segments.
Injectable Pharmaceuticals
This segment caters to the growing demand for injectable medicines, particular...
Caplin Point Laboratories Questions and Answers
Which sectors generate sales and which are the top 3 markets?
**Industry Revenues:**
- Pharmaceuticals: 70%
- Healthcare services: 20%
- Research and development: 10%
**TOP 3 Markets:**
- India: 40%
- Latin America: 30%
- Africa: 20%
Caplin Point Laboratories Limited generates the majority of its revenues from the pharmaceutical industry, indicating its stro...
At which locations are the company’s products manufactured?
**Production Sites:** India, Latin America
Caplin Point Laboratories Limited mainly produces its products in India, where it operates several production facilities. These sites specialize in the manufacturing of pharmaceutical products and meet international quality standards.
In addition, the com...
What strategy does Caplin Point Laboratories pursue for future growth?
**Revenue Growth:** Estimated at 10-12% annually (based on historical data and industry trends until 2023)
**Focus Markets:** Latin America, Africa, and Southeast Asia
Caplin Point Laboratories Limited is pursuing a growth strategy that heavily focuses on expanding into emerging markets. The comp...
Which raw materials are imported and from which countries?
**Main raw materials:** Active pharmaceutical ingredients (APIs), excipients
**Main importing countries:** China, India, Germany
Caplin Point Laboratories Limited mainly imports active pharmaceutical ingredients (APIs) and excipients that are required for the manufacturing of their products. A lar...
How strong is the company’s competitive advantage?
**Return on Equity (ROE):** 20% (2025)
**Net Profit Margin:** 18% (2025)
**Market Share in Segment:** 5% (estimated, 2025)
Caplin Point Laboratories Limited has a significant competitive advantage, reflected in a high Return on Equity (ROE) of 20% in 2025. This metric indicates that the company...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** approximately 12% (2026, estimated)
**Insider Purchases/Sales:** No significant transactions in the last year (2025)
The institutional investor share in Caplin Point Laboratories Limited is around 12%. This indicates that a certain portion of the shares is held by...
What percentage market share does Caplin Point Laboratories have?
**Market share of Caplin Point Laboratories Limited:** Estimated 2-3% (2026)
**Top competitors and their market shares:**
1. Sun Pharmaceutical Industries Ltd. - approx. 8-10%
2. Dr. Reddy's Laboratories Ltd. - approx. 7-9%
3. Cipla Ltd. - approx. 6-8%
4. Lupin Ltd. - approx. 5-7%
5. Aurobindo...
Is Caplin Point Laboratories stock currently a good investment?
**Revenue Growth:** 18% (2025)
**Profit Growth:** 20% (2025)
**R&D Investments:** 10% of revenue (2025)
Caplin Point Laboratories Limited recorded strong revenue growth of 18% in 2025, attributed to successful expansion into new markets and the introduction of new products. The company also ach...
Does Caplin Point Laboratories pay a dividend – and how reliable is the payout?
**Dividend Yield:** 0.5% (estimated for 2026)
**Dividend History:** No regular payouts in recent years
Caplin Point Laboratories Limited has not paid regular dividends in the past. The company traditionally focuses more on reinvesting in business growth and expansion, especially in international...
